UPCOMING EVENTS FOR the 2018-2019 Academic Year

12th Annual PIPG Symposium - Streaming as Disruptive Technology: Changing Media and its impact on copyright law

Keynote: Dorothy Attwood (Senior Vice President of Global Public Policy, The Walt Disney Company)
Thursday, March 28, 2019 (all day), Location TBD

The focus of this year's symposium is to explore key issues surrounding the effect of internet streaming on copyright law.

Do NPEs Enhance the value of Innovation?

Wednesday, March 20, 2019 at 4:30 PM, Silverman 144

Joint PIPG, CTIC, and Professor David Abrams’s Patent Valuation Class to hear Peter Detkin and Kevin Jakel discuss whether NPE senhance the value of patents and innovation.

Terrorism, The first Amendment, and the internet

Thursday, March 14, 2019 at 12 PM, Silverman 280

Professor Alexander Tsesis will give a speech discussing terrorist advocacy on the Internet, which raises special problems because it contains elements of political declaration and self-expression, which are typically protected by the First Amendment. This event is co-sponsored by PIPG, the Brandeis Center, and the Penn Law Veterans Club.

Intellectual Property Litigation Panel

Moderated by Cynthia Dahl (Practice Professor of Law; Director, Detkin Intellectual Property and Technology Legal Clinic)
Panelists: Rob Shaffer (Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP), Julie Goldemberg, L’12 (Associate, Morgan, Lewis & Bockius LLP), Molly Grammel, L’13 (Associate, Goodwin Proctor LLP), Golda Lai, L’16 (Associate, Paul, Weiss, Rifkind, Wharton & Garrison LLP)
Wednesday, February 27, 2019 at 4:30 PM, Gittis 2, Great Hall

A panel discussion will be held to discuss what Intellectual Property Litigation looks like in a law firm and how students can best prepare themselves for interviews for intellectual property litigation jobs. A reception for attendees and the panelists will follow.

Roundtable Discussion of the Loyola Patent fair

Wednesday, February 20, 2019 at 12 pm, Tanenbaum 142

PIPG will host an informal roundtable discussion for students to learn more about how OCI at Loyola differs from OCI at Penn and answer any questions students might have about Loyola prior to the registration deadline on Thursday, February 28, 2019.

You Would not look good in an orange jumpsuit: AVOIDING UNCLEAN HANDS AND INEQUITABLE CONDUCT

Tuesday, February 5, 2019 at 12 pm, Location TBD

Tom Irving, a partner at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will discuss the United States Court of Appeals for the Federal Circuit’s recent decision in Gilead v. Merck and the role of unclean hands and inequitable conduct in patent law.

Intellectual Property Clerkship Panel

Moderated by Christopher Yoo (John H. Chestnut Professor of Law, Communication, and Computer & Information Science; Director, Center for Technology, Innovation, and Competition)
Panelists: The Honorable Kent A. Jordan of the United States Court of Appeals for the Third Circuit, Matthew Pearson, L’05 (Akin Gump), Matthew Lembo, L’17, and Samuel Harrison, L’13
Tuesday, January 29, 2019 at 4:30 pm, Silverman 147

Penn Law Professor Christopher Yoo will moderate a panel discussing the process for applying to clerkships and the benefits of clerking with an intellectual property focus. The panel will include a federal judge and former law clerks from patent-heavy jurisdictions.

1L SUMMER Experience Panel

Monday, November 12, 2018 at 3 pm, Silverman 240A

Join the Penn Intellectual Property Group’s upperclassmen for a panel discussion on how to land the perfect 1L summer internship in intellectual property law. The discussion will cover in-house, law firm, and governmental internships.

Patent Law and Biologic Drugs

Wednesday, September 26, 2018 at 12 pm, Gittis 01

A lunchtime discussion will be held by David Frazier, a partner at Latham & Watkins. Dr. Frazier will be discussing his experience as a patent litigator with particular focus on the Biologics Price Competition and Innovation Act (BPCIA). Enacted in 2009, the BPCIA created a pathway for faster approval of bio similar drugs and figures to factor heavily in the future generic drug markets.